Department of Neurosurgery, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.
Department of Neurosurgery, Krishna Institute of Medical Sciences, Secunderabad, Telangana, India.
Neurol India. 2021 Nov-Dec;69(Supplement):S429-S433. doi: 10.4103/0028-3886.332266.
Hydrocephalus associated with subarachnoid hemorrhage is a common neurosurgical problem, the management of which is tailor-made to the patient. It is usually seen with an aneurysmal bleed and is independent of the primary modality of treatment.
This study aimed to provide a comprehensive overview of this important association and discuss the various available treatment modalities.
A detailed review of the literature was done on the risk factors, pathogenesis, and treatment of hydrocephalus in the setting of subarachnoid hemorrhage.
Hydrocephalus occurs in 6% to 67% of subarachnoid hemorrhage (SAH). It may present as acute, subacute, or chronic at the time of presentation. Diagnosis is made with a plain computed tomography scan of the brain, and the treatment is observant, temporary, or permanent cerebrospinal fluid diversion.
Hydrocephalus associated with SAH interferes with the outcome of SAH. It prolongs the hospital stay, besides causing additional morbidity. The various risk factors, if present, should warn us to be vigilant, and management is definitely not uniform and is custom made to the patients' needs.
蛛网膜下腔出血相关的脑积水是一种常见的神经外科问题,其管理是根据患者的具体情况量身定制的。它通常与动脉瘤性出血有关,且不依赖于主要的治疗方式。
本研究旨在全面概述这种重要的关联,并讨论各种可用的治疗方法。
对蛛网膜下腔出血背景下脑积水的危险因素、发病机制和治疗进行了详细的文献回顾。
脑积水发生在 6%至 67%的蛛网膜下腔出血(SAH)患者中。它可能在发病时表现为急性、亚急性或慢性。诊断通过脑平扫 CT 扫描进行,治疗方法为观察、临时或永久性脑脊液分流。
蛛网膜下腔出血相关的脑积水会影响蛛网膜下腔出血的预后。它延长了住院时间,并且导致了更多的发病率。如果存在各种风险因素,我们应该保持警惕,管理方法肯定不是统一的,而是根据患者的需求定制的。